Literature DB >> 2183890

Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes.

S Vadhan-Raj, W N Hittelman, J L Lepe-Zuniga, J U Gutterman, H E Broxmeyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2183890

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Serial changes in endogenous erythropoietin levels in patients with myelodysplastic syndromes and aplastic anemia undergoing erythropoietin treatment.

Authors:  Y Yoshida; N Anzai; H Kawabata; Y Kohsaka; M Okuma
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

Review 2.  Hematopoietic growth factors and the treatment of tumor-associated anemias.

Authors:  U Dührsen; D K Hossfeld
Journal:  Ann Hematol       Date:  1994-11       Impact factor: 3.673

3.  Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: a clinical and erythrokinetic assessment.

Authors:  G E Verhoef; P Zachée; A Ferrant; H Demuynck; D Selleslag; L Van Hove; F Deckers; M A Boogaerts
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.